A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance
Stephen C. Pflugfelder(Baylor College of Medicine), Roger Vogel, Edward J. Holland(Sentara Norfolk General Hospital), James Chodosh(University of New Mexico), Teresa Micuda, Steven L. Maskin(Ocular Surface Center), Bruce D. Anderson, Cintia S. de Paiva(Baylor College of Medicine), S P Bartels, Howard M. Proskin(MDS Associates (United States))
Cited by 231
Related Papers
Corneal transplantation
|The Lancet|2012|799
Dry Eye as a Mucosal Autoimmune Disease
|International Reviews of Immunology|2013|339
Pheno-Copter: A Low-Altitude, Autonomous Remote-Sensing Robotic Helicopter for High-Throughput Field-Based Phenotyping
|Agronomy|2014|286
The AcrySof Toric Intraocular Lens in Subjects with Cataracts and Corneal Astigmatism
|Ophthalmology|2010|268